A Potential Treatment for Idiopathic Pulmonary Fibrosis Earns Orphan Drug Designation
According to a story from Financial Buzz, the biotherapeutics company Bellerophon Therapeutics Inc. has recently announced that it has earned Orphan Drug designation from the US Food and Drug Administration…